Pharmacovigilance Blog

Drug safety and pharmacovigilance

The Importance of Reporting Adverse Event(s)

In this comprehensive blog, we delve into why reporting adverse events is crucial for public safety and discuss the concerning issue of the rapid and widespread lack of adverse event reports.

Bala

Read

ICSR Management

Decoding Medical Review in Pharmacovigilance

Discover the role of the medical review in pharmacovigilance, including its responsibilities and eligibility criteria. Click to delve deeper into this insightful exploration. Read more here.

Bala

Read

Drug safety and pharmacovigilance

Drug safety and pharmacovigilance: The difference

In this article we explore in to the difference between the terms drug safety and pharmacovigilance. While many of us thinking both are interchangeable, they actually have a distinct meaning. So you land on the right place to clarify and gain knowledge about it.

Bala

Read

Drug safety and pharmacovigilance

Decoding Risk: Why RCA Matters in Pharmacovigilance

In this blog, you’ll explore into the importance and procedures of conducting Root Cause Analysis (RCA) in pharmacovigilance, accompanied by relevant references for deeper understanding.

Bala

Read

Public Authorities and Safety

Contribution of CIOMS in Pharmacovigilance: An overview

In this comprehensive blog, we will delve into the fundamentals and history of CIOMS, the Council for International Organizations of Medical Sciences. While many of us are aware that CIOMS is a non-profit organization, its significance goes beyond that.

Bala

Read

Drug safety and pharmacovigilance

Examining Drug Types in PV: Suspected and Concomitant

Welcome to our informative pharmacovigilance blog, where we shed light on the distinction between suspected drugs and concomitant drugs. Gain a deeper understanding of the roles and implications of suspected drugs in post-marketing surveillance and adverse event reporting.

Bala

Read

Techs & Tools

Insights into Pharmacovigilance: Social Media’s Influence

Explore the expanding landscape of adverse event (AE) reporting through social medias, uncovering key definitions, and navigating the handling of AE reports. As this system gains momentum, delve into the evolving future and the platforms that will shape its development. Discover the foundations and mechanisms essential for initiating widespread engagement.

Bala

Read

Drug safety and pharmacovigilance

Evaluation of Benefit-Risk Balance in Pharmacovigilance

In this detailed blog, we delve into the specific aspects of the benefit-risk evaluation process, accompanied by a flow diagram illustrating the sequential steps for proper implementation.

Bala

Read